The US FDA is warning consumers and healthcare providers against using bismacine, also known as chromacine
- PDF / 136,195 Bytes
- 1 Pages / 623.591 x 841.847 pts Page_size
- 104 Downloads / 184 Views
1
■ The US FDA is warning consumers and healthcare providers against using bismacine, also known as chromacine. The agency says that it is investigating one report of death and several reports of injury associated with bismacine use. According to the agency, injectable Bismacine is not a pharmaceutical, is not approved for anything, and contains high amounts of bismuth, which is not approved for use by injection. The FDA says that one person has died, one was hospitalised and others experienced serious adverse events after receiving bismacine. The agency also states that possible effects of bismuth poisoning include renal failure and cardiovascular collapse. FDA. FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine. Media Release : 21 Jul 2006. Available from: URL: http://www.fda.gov
809065805
0114-9954/10/1112-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
Reactions 29 Jul 2006 No. 1112
Data Loading...
